4.7 Article

Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide-induced ERK/Egr-1 pathway

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Calorie restriction ameliorates hyperglycemia, modulates the disordered gut microbiota, and mitigates metabolic endotoxemia and inflammation in type 2 diabetic rats

L. Zhang et al.

Summary: This study found that calorie restriction can ameliorate hyperglycemia by altering the structure and function of gut microbiota, reducing metabolic endotoxemia and inflammation levels.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Biochemistry & Molecular Biology

Acetylcholine exerts cytoprotection against hypoxia/reoxygenation-induced apoptosis, autophagy and mitochondrial impairment through both muscarinic and nicotinic receptors

Kannaporn Intachai et al.

Summary: Acetylcholine exerts cardioprotection against H/R-induced apoptosis, autophagy, and mitochondrial impairment through the activation of both muscarinic and nicotinic receptors.

APOPTOSIS (2022)

Article Endocrinology & Metabolism

Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults

Matti O. Ruuskanen et al.

Summary: This study examined the long-term association between gut microbiome composition and incident type 2 diabetes. The findings identified specific species and clusters of bacteria that were consistently associated with incident diabetes and suggested potential therapeutic targets for the disease.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

Hong Sun et al.

Summary: This study provides global, regional, and country-level estimates of diabetes prevalence and health expenditures for 2021 and projections for 2045. The global prevalence of diabetes is increasing and is expected to have the greatest relative increase in middle-income countries. Diabetes-related health expenditures are also projected to rise.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Review Oncology

Hyperglycemic memory in diabetic cardiomyopathy

Jiabing Zhan et al.

Summary: Cardiovascular diseases are the leading cause of death in individuals with diabetes, with diabetic cardiomyopathy as a major complication. Hyperglycemia triggers multiple pathways leading to pathological changes in the heart. Intensive glycemic control does not reduce hospitalization and mortality in heart failure patients with diabetes, indicating a persistent hyperglycemic stress known as the hyperglycemic memory phenomenon.

FRONTIERS OF MEDICINE (2022)

Article Pharmacology & Pharmacy

Canagliflozin Prevents Lipid Accumulation, Mitochondrial Dysfunction, and Gut Microbiota Dysbiosis in Mice With Diabetic Cardiovascular Disease

Xueliang Wang et al.

Summary: Canagliflozin has shown potential in relieving cardiovascular disease in mice with type 2 diabetes by improving gut microbiota composition and myocardial mitochondrial homeostasis.

FRONTIERS IN PHARMACOLOGY (2022)

Article Cell Biology

TRPM2 Promotes Atherosclerotic Progression in a Mouse Model of Atherosclerosis

Yunting Zhang et al.

Summary: TRPM2 plays a promoting role in the progression of hypercholesterolemia-induced atherosclerosis by linking ROS to Ca2+ and inflammation.

CELLS (2022)

Article Pharmacology & Pharmacy

Zi Shen Wan Fang Attenuates Neuroinflammation and Cognitive Function Via Remodeling the Gut Microbiota in Diabetes-Induced Cognitive Impairment Mice

Jiangwei Shi et al.

Summary: The study found that ZSWF can improve cognitive function in DCI mice by regulating intestinal microbial homeostasis, reducing inflammation levels, restoring intestinal barrier integrity, and reshaping the structure of gut microbiota.

FRONTIERS IN PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

A novel therapeutic combination of dapagliflozin, Lactobacillus and crocin attenuates diabetic cardiomyopathy in rats: Role of oxidative stress, gut microbiota, and PPARγ activation

Eman M. Khalaf et al.

Summary: This study demonstrated the synergistic effect of the triple combination of dapagliflozin, crocin prebiotic, and Lactobacillus probiotics in treating diabetic cardiomyopathy in rats, significantly reducing oxidative, inflammatory, and apoptotic activities, and helping to restore symbiotic gut microbiota.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Article Endocrinology & Metabolism

Tang-Ping-San Decoction Remodel Intestinal Flora and Barrier to Ameliorate Type 2 Diabetes Mellitus in Rodent Model

Wen Yin et al.

Summary: This study evaluated the therapeutic effect of TPS decoction on mice with T2DM and found that it can improve hyperglycemia, hyperlipidemia, insulin resistance, pathological organ changes, and inflammatory reactions. Furthermore, TPS decoction can also reverse gut microbiota dysfunction and repair the intestinal mucosal barrier.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2022)

Article Cardiac & Cardiovascular Systems

Functional components of Chinese rice wine can ameliorate diabetic cardiomyopathy through the modulation of autophagy, apoptosis, gut microbiota, and metabolites

Jinjin Yang et al.

Summary: Rice wine polyphenols, polypeptides, and oligosaccharides can ameliorate diabetic cardiomyopathy by promoting autophagy, inhibiting apoptosis, and reversing gut microbiota dysbiosis and metabolic dysregulation.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Endocrinology & Metabolism

Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults

Matti O. Ruuskanen et al.

Summary: The study identified specific gut microbiome compositions that were predictive of incident type 2 diabetes during long-term follow-up. These findings support the association between dietary habits, metabolic diseases, and type 2 diabetes, which are influenced by the gut microbiome.

DIABETES CARE (2022)

Review Cell Biology

The Role of α7nAChR-Mediated Cholinergic Anti-inflammatory Pathway in Immune Cells

Yi-jin Wu et al.

Summary: Research suggests that Alpha 7 nicotinic acetylcholine receptor (α7nAChR) plays a crucial role in regulating inflammatory responses, with activation of this receptor significantly reducing inflammation. However, the mechanism through which the cholinergic anti-inflammatory pathway (CAP) curbs excessive pro-inflammatory responses and maintains immune homeostasis is not fully understood, requiring further studies to elucidate.

INFLAMMATION (2021)

Article Endocrinology & Metabolism

Role of the gut microbiota in type 2 diabetes and related diseases

Ge Yang et al.

Summary: Type 2 diabetes is the fastest-growing metabolic disease in the world, with patients often experiencing disturbances in the gut microbiota and increased intestinal permeability. The gut microbiota, which plays a crucial role in metabolism and immune regulation, may serve as a potential therapeutic target for improving the outcomes of type 2 diabetes and related diseases.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Article Medicine, Research & Experimental

Amelioration of circadian disruption and calcium-handling protein defects by choline alleviates cardiac remodeling in abdominal aorta coarctation rats

Xi He et al.

Summary: The study demonstrated that choline can attenuate cardiac remodeling and dysfunction induced by abdominal aortic coarctation by improving circadian rhythm disruption and calcium-handling protein defects. Modulation of vagal activity by choline holds therapeutic potential for treating cardiac remodeling and heart failure.

LABORATORY INVESTIGATION (2021)

Review Cardiac & Cardiovascular Systems

Early Growth Response-1, an Integrative Sensor in Cardiovascular and Inflammatory Disease

Levon M. Khachigian

Summary: Egr-1 serves as a master regulator and transcriptional sensor in vascular dysfunction and disease, amplifying pathologic signals by inducing the expression of proliferative, migratory, and proinflammatory genes. Targeting Egr-1 may offer therapeutic benefits in cardiovascular and inflammatory disorders.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Review Biochemistry & Molecular Biology

Peripheral CB1R as a modulator of metabolic inflammation

Ji Hye Han et al.

Summary: The review highlights the role of peripheral CB1R in metabolic inflammation and its involvement in various metabolic disorders such as insulin resistance. It also discusses the therapeutic potential of second- and third-generation peripherally restricted CB1R antagonists for treating obesity-induced metabolic inflammation without causing central CB1R-mediated neurobehavioral effects.

FASEB JOURNAL (2021)

Article Biochemistry & Molecular Biology

Mixed conjugated linoleic acid sex-dependently reverses high-fat diet-induced insulin resistance via the gut-adipose axis

Haoyu Li et al.

Summary: Conjugated linoleic acid (CLA) can decrease body weight and increase energy expenditure through the gut-adipose axis, but it modulates insulin resistance in a sex-dependent manner in both males and females.

FASEB JOURNAL (2021)

Review Nutrition & Dietetics

Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites

Sonia Croci et al.

Summary: This passage discusses the relationship between metabolic syndrome and gut microbiota, indicating that dysbiosis may play a role in the pathogenesis of various chronic diseases; certain metabolites derived from microorganisms can trigger subclinical inflammatory processes related to MetS.

NUTRIENTS (2021)

Article Immunology

Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy

Yinhua Huang et al.

Summary: The study revealed compositional alterations of gut microbiota in patients with type 2 diabetes and diabetic retinopathy, as well as identified bacterial families that could distinguish different groups, which might serve as non-invasive biomarkers for clinical and differential diagnosis.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Pharmacology & Pharmacy

Pyridostigmine Protects Against Diabetic Cardiomyopathy by Regulating Vagal Activity, Gut Microbiota, and Branched-Chain Amino Acid Catabolism in Diabetic Mice

Yang Yang et al.

Summary: The disruption of gut microbes, BCAA catabolism, and vagal activity in diabetic cardiomyopathy mice were improved by pyridostigmine, leading to reduced cardiac damage. This study provides new insights for developing therapeutic strategies targeting gut microbes and BCAA metabolism to alleviate diabetes-induced cardiac injury.

FRONTIERS IN PHARMACOLOGY (2021)

Review Endocrinology & Metabolism

Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes

Jin Joo Park

Summary: Diabetes increases the risk of cardiovascular disease by affecting vascular homeostasis and myocardial function. Prognosis is worse in heart failure patients with diabetes compared to those without diabetes.

DIABETES & METABOLISM JOURNAL (2021)

Article Food Science & Technology

Dietary synbiotic ameliorates constipation through the modulation of gut microbiota and its metabolic function

Zhandong Yang et al.

Summary: The study revealed that the novel synbiotic alleviated constipation by modulating gut microbiota, promoting short-chain fatty acids production, and inhibiting inflammatory responses. This suggests that the synbiotic may offer a promising alternative treatment strategy for constipation in the future.

FOOD RESEARCH INTERNATIONAL (2021)

Article Peripheral Vascular Disease

Pyridostigmine ameliorates preeclamptic features in pregnant rats by inhibiting tumour necrosis factor-α synthetsis and antagonizing tumour necrosis factor-α-related effects

Abdoulaye Issotina Zibrila et al.

Summary: The study showed that PYR alleviated hypertension and other symptoms of preeclampsia in rat models by inhibiting TNF-α synthesis and directly counteracting its detrimental effects. This suggests that PYR may be a potential agent for preeclampsia management and warrants further investigation.

JOURNAL OF HYPERTENSION (2021)

Article Endocrinology & Metabolism

Metformin Improves Autonomic Nervous System Imbalance and Metabolic Dysfunction in Monosodium L-Glutamate-Treated Rats

Claudineia Conationi da Silva Franco et al.

Summary: The study showed that metformin can improve autonomic nervous system function in obese rats, normalize cholinergic response in pancreatic beta-cells, and alleviate obesity by reducing protein expression of M3 mAChRs.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Gastroenterology & Hepatology

Prebiotic Enriched Exclusive Enteral Nutrition Suppresses Colitis via Gut Microbiome Modulation and Expansion of Anti-inflammatory T Cells in a Mouse Model of Colitis

Genelle R. Lunken et al.

Summary: The EEN IN group demonstrated reduced colitis development compared to the chow and EEN groups, highlighting the potential benefits of EEN IN as a novel induction therapy for pediatric CD and UC patients.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Peripheral Vascular Disease

The Influence of Gut Microbiota on the Cardiovascular System Under Conditions of Obesity and Chronic Stress

Piotr Dubinski et al.

Summary: Microbiota is considered an integral part of the human body, with the gut being one of the most heavily colonized areas. Factors like obesity and chronic stress can differential regulate the gut microbiota gradient. Recent findings suggest that gut microbiota and its metabolites may play a significant role in the pathogenesis of cardiovascular diseases under conditions such as obesity and chronic stress.

CURRENT HYPERTENSION REPORTS (2021)

Review Endocrinology & Metabolism

The gut microbiota and diabetic cardiomyopathy in humans

M. Bastin et al.

DIABETES & METABOLISM (2020)

Review Hematology

The gut microbiome and thromboembolism

Rida Abid Hasan et al.

THROMBOSIS RESEARCH (2020)

Review Biochemistry & Molecular Biology

Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway

Pui-Kei Wu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Cardiac & Cardiovascular Systems

Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease

Caitlin Lewis et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)

Review Biochemistry & Molecular Biology

Gut Microbiota and Intestinal Trans-Epithelial Permeability

Benedicte Allam-Ndoul et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Endocrinology & Metabolism

Risk Factors Associated with Cardiac Autonomic Modulation in Obese Individuals

Camila Oliveira et al.

JOURNAL OF OBESITY (2020)

Review Immunology

The intestinal microbiota fuelling metabolic inflammation

Herbert Tilg et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

Pyridostigmine alleviates cardiac dysfunction via improving mitochondrial cristae shape in a mouse model of metabolic syndrome

Run-Qing Xue et al.

FREE RADICAL BIOLOGY AND MEDICINE (2019)

Review Neurosciences

Pharmacological Modulation of Vagal Nerve Activity in Cardiovascular Diseases

Longzhu Liu et al.

NEUROSCIENCE BULLETIN (2019)

Article Medicine, Research & Experimental

Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy

Liyuan Jin et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Article Biochemistry & Molecular Biology

Regulation of mitochondrial cristae remodelling by acetylcholine alleviates palmitate-induced cardiomyocyte hypertrophy

Run-Qing Xue et al.

FREE RADICAL BIOLOGY AND MEDICINE (2019)

Article Medicine, Research & Experimental

Immunomodulatory role of nonneuronal cholinergic signaling in myocardial injury

Cibele Rocha-Resende et al.

JCI INSIGHT (2019)

Article Biochemistry & Molecular Biology

Pyridostigmine protects against cardiomyopathy associated with adipose tissue browning and improvement of vagal activity in high-fat diet rats

Yi Lu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

Article Medicine, Research & Experimental

Alamandine attenuates sepsis-associated cardiac dysfunction via inhibiting MAPKs signaling pathways

Peng Li et al.

LIFE SCIENCES (2018)

Review Cell Biology

Distribution and function of the muscarinic receptor subtypes in the cardiovascular system

Hannah C. Saternos et al.

PHYSIOLOGICAL GENOMICS (2018)

Article Multidisciplinary Sciences

Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection

Christoph A. Thaiss et al.

SCIENCE (2018)

Review Neurosciences

The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis

Bruno Bonaz et al.

FRONTIERS IN NEUROSCIENCE (2018)

Article Endocrinology & Metabolism

Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice

Shaoqian Zhao et al.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)

Review Endocrinology & Metabolism

Metabolic endotoxemia and diabetes mellitus: A systematic review

Junia Maria Geraldo Gomes et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2017)

Review Endocrinology & Metabolism

Cardiovascular risk assessment in patients with diabetes

Marcello Casaccia Bertoluci et al.

DIABETOLOGY & METABOLIC SYNDROME (2017)

Review Medicine, General & Internal

Gut microbiota, obesity and diabetes

Elaine Patterson et al.

POSTGRADUATE MEDICAL JOURNAL (2016)

Article Multidisciplinary Sciences

Improving vagal activity ameliorates cardiac fibrosis induced by angiotensin II: in vivo and in vitro

Jin-Jun Liu et al.

SCIENTIFIC REPORTS (2015)

Article Physiology

Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus

Jennifer Lee et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2012)

Article Critical Care Medicine

Stimulating the Central Nervous System to Prevent Intestinal Dysfunction After Traumatic Brain Injury

Vishal Bansal et al.

JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2010)

Article Critical Care Medicine

Efferent Vagal Nerve Stimulation Attenuates Gut Barrier Injury After Burn: Modulation of Intestinal Occludin Expression

Todd W. Costantini et al.

JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2010)

Article Gastroenterology & Hepatology

ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding

R Kishore et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)

Article Multidisciplinary Sciences

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

LV Borovikova et al.

NATURE (2000)